Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
As Needed vs Regular Fluticasone Furoate in Pediatric Perennial Allergic Rhinitis
NCT05299086Phase 3Completed
- Sponsor
- Mahidol University
- Start
- Apr 2022
- Primary completion
- Mar 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fluticasone in perennial allergic rhinitis (PAR), sponsored by Mahidol University. Started Apr 2022; status: completed.
02
Drugs
fluticasone
03
Conditions
perennial allergic rhinitis (PAR)
Beyond the preview
Go deeper on NCT05299086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05299086.